Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: LJM	12/16/2005 9:41:03 PM
	of 946

*DJ Cell Therapeutics Registers $82M Conv Notes For Holders 16 Dec 17:18 DJ Cell Therapeutics Registers $82M Of Conv Notes For Hldrs 16 Dec 17:46 WASHINGTON (Dow Jones)--Cell Therapeutics Inc. (CTIC) on Friday registered on behalf of holders $82 million of convertible notes and about 31.54 million common shares issuable upon conversion of the notes, according to a Form S-3 filed with the Securities and Exchange Commission. The company said it issued the 6.75% convertible senior notes due 2010 in a private placement in November, with a conversion rate of 380.37 shares per each $1,000 principal amount of notes, or an initial conversion price of about$2.63 per share of common stock. The company will pay interest on the notes on April 30 and Oct. 31 of each year, starting April 30, 2006, the filing said. The company said it won't receive any proceeds from the sale of the notes and the shares by the selling holders. Seattle-based Cell Therapeutics develops treatments for cancer. Shares of the company closed Friday at $2.34 each, up 5 cents. -By Denise Jia, Dow Jones Newswires; 202-862-1359; denise.jia@dowjones.com (END) Dow Jones Newswires 12-16-05 1746ET Copyright (c) 2005 Dow Jones & Company, Inc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next